Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 488,100 | 410,377 | 406,913 | 433,280 | 403,800 |
| Marketable Securities | 1,176,400 | 1,217,641 | 1,214,753 | 1,217,954 | 1,208,900 |
| Receivables | 452,500 | 461,940 | 445,506 | 444,809 | 489,000 |
| Inventories | 760,000 | 804,276 | 803,693 | 783,369 | 780,500 |
| Other current assets | 30,700 | 28,158 | 32,376 | 38,782 | 26,100 |
| TOTAL | $3,030,300 | $3,055,620 | $3,056,254 | $3,060,936 | $3,048,300 |
| Non-Current Assets | |||||
| PPE Net | 528,100 | 545,304 | 533,767 | 522,364 | 529,000 |
| Investments And Advances | 4,839,200 | 6,002,635 | 5,099,554 | 8,018,383 | 7,698,100 |
| Intangibles | 704,100 | 722,425 | 719,209 | 726,419 | 734,100 |
| Other Non-Current Assets | 262,400 | 277,489 | 279,662 | 281,791 | 289,600 |
| TOTAL | $6,333,800 | $7,547,853 | $6,632,192 | $9,548,957 | $9,250,800 |
| Total Assets | $9,364,100 | $10,603,470 | $9,688,446 | $12,609,890 | $12,299,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,200 | 1,262 | 483 | 487 | 500 |
| Accounts payable and accrued liabilities | 122,300 | 122,185 | 126,693 | 102,750 | 144,600 |
| Accrued Expenses | 124,200 | 146,024 | 132,460 | 146,491 | 139,900 |
| Other current liabilities | 147,200 | 142,013 | 149,916 | 142,427 | 161,600 |
| TOTAL | $467,800 | $497,943 | $486,961 | $466,154 | $522,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,200,400 | 1,200,062 | 1,199,724 | 1,199,381 | 1,199,100 |
| Other Non-Current Liabilities | 308,600 | 341,550 | 344,512 | 352,232 | 360,500 |
| TOTAL | $2,327,000 | $2,617,670 | $2,422,698 | $3,092,605 | $3,035,100 |
| Total Liabilities | $2,794,800 | $3,115,613 | $2,909,659 | $3,558,759 | $3,557,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,011 | 27,997 | 27,871 | 28,525 | 28,518 |
| Common Shares | N/A | 3 | 3 | 3 | N/A |
| Retained earnings | 7,416,400 | 8,132,231 | 7,479,059 | 9,644,545 | 9,260,600 |
| Other shareholders' equity | -538,300 | -315,704 | -451,004 | -426,041 | -335,500 |
| TOTAL | $6,569,300 | $7,487,859 | $6,778,787 | $9,051,134 | $8,741,200 |
| Total Liabilities And Equity | $9,364,100 | $10,603,472 | $9,688,446 | $12,609,893 | $12,299,100 |